Currently out of the existing stock ratings of Lee Hambright, 31 are a HOLD (36.05%), 52 are a BUY (60.47%), 3 are a SELL (3.49%).

Lee Hambright

Work Performance Price Targets & Ratings Chart

Analyst Lee Hambright, currently employed at BERNSTEIN, carries an average stock price target met ratio of 68.63% that have a potential upside of 18.84% achieved within 233 days.

Lee Hambright’s has documented 167 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MDT, Medtronic PLC at 05-Jun-2026.

Wall Street Analyst Lee Hambright

Analyst best performing recommendations are on TNDM (TANDEM DIABETES CARE).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 11/10/2025. The price target of $18 was fulfilled within 2 days with a profit of $1.63 (9.96%) receiving and performance score of 49.79.

Average potential price target upside

of $58.41 (22.36%) on ISRG (INTUITIVE SURGICAL).
of $55.1 (21.25%) on PODD (INSULET).
of $33.88 (13.96%) on SYK (STRYKER).

EW Edwards Lifesciences Corp MDT Medtronic PLC JNJ Johnson & Johnson ZBH Zimmer Biomet Holdings SYK Stryker ABT Abbott Laboratories ISRG Intuitive Surgical DXCM DexCom BSX Boston Scientific Corp PODD Insulet TNDM Tandem Diabetes Care

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Joanne Wuensch (CITI)